| |
| | Patent 6,630,318 |
 | | Adaptor proteins which may be components of the PTK/adaptor protein complexes of the invention, may include, for example, SHC, ISGF3.alpha., and members of the GRB subfamily of proteins, such as GRB-1/p85, GRB-2, GRB-3/c-Crk, GRB-4/Nck, GRB-7, and GRB-10, with GRB-7 being a preferred adaptor protein component of the PTK/adaptor protein complex of the invention. |
 | | New members of the PTK and/or adaptor protein families capable of forming the complexes of the invention may be identified and isolated by molecular biological techniques well known in the art. |
 | | Briefly, new members of the adaptor family of proteins may be identified by their ability to specifically bind to at least a portion of a tyrosine-phosphorylated peptide comprising an adaptor-protein-binding region. |
| pharmcast.com /Patents/Yr2003/Oct2003/100703/6630318_Cancer100703.htm (11086 words) |
|